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We analyzed 19 chromophobe renal ceU carcino-
mas by means ofcomparativegenomic hybridiza-
tion. Two tumors revealed no numerical abnor-
malities. In the remaining 17 cases wefound loss
ofentire chromosomes with underrepresentation
ofchromosome 1 occurring in aU 1 7cases; loss of
chromosomes 2, 10, and 13 in 16 cases; loss of
chromosomes 6 and 21 in 15 tumors; and loss of
chromosome 1 7 in 13 cases. The loss ofthe Ychro-
mosome was observed in 6 of 13 tumors from
malepatients, whereas 1Xchromosome was lost
in 3 of4 tumors obtainedfromfemales. Compara-
tive genomic hybridization results were verified
by interphase cytogenetics. We conclude that a
specific combination of multiple chromosomal
losses characterizes chromophobe renal ceU
carcinomas and may help to differentiate them
unequivocaly from other types of kidney
cancer. (AmJPathol 1994, 145:356-364)
Recently, a new cytological type of human renal cell
carcinoma (RCC) referred to as chromophobe RCC,
which comprises approximately 5% of renal cell tu-
mors, was described.1 The unique morphological
pattern of chromophobe cells was first recognized
among experimentally induced renal tumors of the
rat.2 Chromophobe RCC is characterized by com-
pact growth of tumor cells having a pale, fine reticular
cytoplasm. The cytoplasm of chromophobe cells
shows a diffuse reaction with Hale's acid iron colloid
stain. Ultrastructurally, chromophobe cells display
pathognomic cytoplasmic vesicles and a variable
number of normal and morphologically altered mito-
chondria.3'4 Only few reports describing the genetic
changes of chromophobe RCCs have been pub-
lished.5-9 A recent restriction fragment length poly-
morphism (RFLP) analysis of chromophobe RCCs re-
vealed a combination of allelic losses at 3p, 5q, and
17, which have not been seen in other genetic sub-
types of kidney cancer and showed a gross rear-
rangement of the mitochondrial DNA.7 A cytogenetic
analysis of two chromophobe RCCs disclosed the
common loss of chromosomes 1, 2, 6,10,13,17, and
21 as well as loss of other chromosomes, yielding a
low chromosome number of 34 and 38, respec-
tively.5,6 Two recent reports described an interstitial
deletion at the short arm of chromosome 11 as the
only karyotype change in a chromophobe RCC8 and
gains of chromosomes 7, 12, 16, 18, 19, and 20.9
In this study we used the new technique of com-
parative genomic hybridization (CGH).10 Briefly, dif-
ferently labeled tumor and normal genomic reference
DNA are hybridized together to normal metaphase
spreads under suppression conditions. 1012 The ratio
between the fluorescence intensities measured along
each normal reference chromosome reflects the rela-
tive copy number of chromosomal segments in tumor
cells, thus displaying relative overrepresentation and
underrepresentation of chromosomal sequences in
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the tumor genome. The usefulness of the CGH tech-
nique to detect gross karyotype changes has been
shown in several studies.13-17 The sensitivity of CGH
allows at present the detection of DNA gains and
losses spanning at least 10 Mbp. In this study we have
produced ratio fluorescence profile karyotypes from
19 chromophobe RCCs. Our report confirms highly
specific combination of chromosomal losses that are
associated with the development of this unique type
of renal cancer.
Materials and Methods
Clinical and Pathological Data
Tumor tissue of 19 chromophobe RCCs was available
for this study. Tumors were diagnosed according to
the histological and cytological criteria described by
Thoenes et al.1 3 This series is comprised of tumors
of 15 men and 4 women aged between 24 and 81
years (Table 1). The maximum diameter of tumors var-
ied between 3.5 and 10 cm. All tumors were removed
surgically, snap-frozen immediately in liquid nitrogen,
and stored at -80 C until DNA was extracted.
Chromosome Preparations
Metaphase spreads for CGH experiments were pre-
pared from phytohemagglutinin-stimulated lympho-
cytes of healthy individuals (46,XX or 46,XY) using
standard procedures of hypotonic treatment and
methanol/acetic acid fixation.
Labeling of DNA Probes
Total genomic DNA from tumor samples and regional
DNA probes, recognizing tandem repetitive se-
quences in the paracentromeric regions of chromo-
somes 1 (pUC1.77)18 and 3 (pa3.5),19 were labeled
with digoxigenin-11-dUTP (Boehringer Mannheim,
Mannheim, Germany) or biotin-1 1-dUTP (Sigma, St.
Louis, MO) using standard nick translation proce-
dures.20
CGH
CGH experiments were performed as described pre-
viously with small modifications.1114 Briefly, approxi-
mately 100 to 200 ng of tumor DNA was hybridized
together with the same amount of normal reference
DNA in the presence of 50 pg Cotl -DNA and 50 pg
sonicated salmon sperm DNA. In situ hybridization
was allowed for 4 to 5 days. After posthybridization
washes, biotin-labeled sequences were visualized
using avidin conjugated to fluorescein isothiocyanate
(FITC) and tetraethylrhodamine isothiocyanatae
(TRITC)-conjugated sheep anti-mouse antibodies for
the detection of digoxigenin-labeled sequences.
DAPI banding was applied to identify individual chro-
mosomes.
Fluorescence Microscopy and Digital
Image Acquisition and Processing
A Zeiss Axiophot microscope with an aligned filter set
for DAPI (LP 450-490, BP 365, FT 395), FITC (LP 515-
565, BP 450-490, FT 510), and TRITC (LP 590, BP
546, FT 580) was used. For image acquisition the mi-
croscope was equipped with a cooled CCD camera
(Photometrics; Kodak KAF, Tucson, AZ). The image
acquisition procedure and image processing were
performed as described.1114 Briefly, gray level im-
ages were taken separately for each fluorochrome
and the DAPI image. Optimal exposure times and op-
tical Settings were chosen to avoid saturation values
and to cover at least half of the total dynamic range
of the camera.
The digital images were processed with programs
developed in our laboratory (S du Manoir et al, manu-
script submitted). Briefly, after subtraction of back-
ground fluorescence intensities and image shift cor-
rection an FITC to TRITC pixel-by-pixel ratio image
was obtained by dividing an FITC image pixel by pixel
by the TRITC image. A lookup table was used for the
visualization of three different gray levels indicating
the range below, within, or above the threshold of the
normal range. Thus, DNA segments both within and
outside the normal range within a single metaphase
spread could be visualized.
To test for the consistency of values outside the
normal range in several metaphase spreads, FITC to
TRITC average ratio profiles were calculated. This
was done by calculation of the medial axis of each
chromosome within the DAPI image, calculation of
FITC and TRITC profiles along individual chromo-
somes, and as a last step an averaging of individual
chromosome ratio profiles from different metaphases.
The central line in the profiles represents the most
frequently measured fluorescence ratio for each ref-
erence metaphase spread, whereas the left and right
vertical lines define emperically determined thresh-
old values for underrepresentations and overrepre-
sentations, respectively. The entire procedure will be
described in detail elsewhere (S du Manoir et al,
manuscript submitted).
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Interphase Cytogenetics
Interphase cytogenetics was performed on single cell
suspensions from five tumors. Cells were incubated
in 1 X phosphate-buffered saline with 1% Tween 20 for
30 minutes at room temperature followed by an in-
cubation in 1 M sodium thiocyanate at 70 C for 30
minutes.21 After washing with distilled H20, digestion
with pepsin (250 pg/ml in 0.2 N HCI) was conducted
at 37 C for approximately 5 to 15 minutes. Postfixation
was performed with 1% paraformaldehyde.
Criteria for the evaluation of FISH signals were as
detailed in.21 Evaluation was performed by counting
at least 100 nuclei/slide. To minimize misinterpreta-
tions and to establish the accurate degree of ploidy,
two-color hybridization experiments were performed
with one probe testing for a chromosome present in
apparently balanced copy number, and a second
probe testing for the chromosome present in unbal-
anced numbers as revealed by cytogenetic analyses
or CGH.
Results
CGH experiments were started with tumors 315, 277,
and 229 because cytogenetic and/or RFLP analysis
data were available for comparisons.5'7 Cytogenetic
analysis for tumor 315 had revealed the karyotype:
34, XY, -1, -2, -3, -6, -7, -9, -10, -12, -13, -17,
-18, and -21.5 Southern analysis using DNA probes
from chromosomes 3, 5, and 17 revealed loss of con-
stitutional heterozygosity (LOH) at the short arms of
chromosomes 3 and 17.7
CGH with DNA from this tumor yielded fluores-
cence intensities over the autosomes at two different
levels: the autosomes 1, 2, 3, 6, 7, 9, 10, 12, 13, 17,
18, and 21 were consistently less intensively painted
than the remaining autosomes (Figure 1,A). In con-
trast, normal reference DNA painted all autosomes
equally except for the constitutive heterochromatin,
which showed very weak if any labeling with both tu-
mor and reference DNA sequences. This effect was
due to Cotl -DNA suppression of the hybridization of
labeled sequences to highly repetitive target DNAs.
The X chromosome yielded lesser fluorescence in-
tensity values than autosomes since the reference
DNA was male (Figure 1 ,B). A lookup table visualized
the different FITC to TRITC fluorescence ratios (Figure
1,C): yellow represents a balanced FITC/TRITC ratio,
whereas red represents a decreased FITC/TRITC
ratio.
For tumor 277 banding analysis had revealed the
karyotype: 37, X, -Y, -1, -2, -6, -10, -13, -15, -17,
and -21 .6 As in tumor 315 two ranges of fluorescence
intensity ratios could be distinguished over the ref-
erence chromosomes. The less intensively painted
chromosomes again corresponded to the mono-
somies of the banding analysis, except for the mono-
somy 15 which could not be verified by CGH (Fig.
2,B). An average ratio profile from 10 metaphase
spreads confirmed unequivocally the occurrence of
only two different fluorescence ratio levels (Figure 3).
RFLP analysis of tumor 229 revealed LOH for DNA
markers on the long arm of chromosome 17 but not
on chromosomes 3p and 5q.7 CGH revealed that
chromosome 17 was one of the less intensively
painted chromosomes, whereas chromosomes 3 and
5 were more intensively painted (Table 1).
In summary, CGH findings for these three tumors,
with the exception of a single chromosome in one
case, were evaluated in complete accordance with
previously established cytogenetic and molecular
genetic data. To test for the consistency of chromo-
some losses, we evaluated a series of other chromo-
phobe RCCs that had not been studied before. Figure
2,D shows a representative example of CGH with
DNA from tumor 691. Again the two different ranges
of fluorescence values with chromosomes 1, 2, 6, 10,
13, and 21 painted less intensively were observed.
Underrepresentations of multiple chromosomes
were found in 17 tumor DNA samples (Table 1, Figure
4). Only in DNA samples from two tumors revealed
CGH a uniform staining over all autosomes without
any consistent overrepresentation or underrepresen-
tation of chromosomal regions. Entire chromosomes
were lost in all but one case; in tumor 680 a loss was
indicated only for the short arm of chromosome 1.
Underrepresentation of chromosome 1 was found in
each other tumor; underrepresentation of chromo-
somes 2, 10, and 13 occurred in 16 cases each; loss
of chromosomes 6 and 21 in 15 tumors; and loss of
chromosome 17 in 13 tumors. The losses of chromo-
somes 3 and 8, chromosomes 9 and 18, and chro-
mosomes 4,5,12,14,15, and 20 occurred in 4,3, and
1 cases, respectively. The loss of the Y chromosome
was observed in 6 of 13 tumors from males, whereas
one of the X chromosomes was lost in 3 of 4 tumors
from females. Thus, seven chromosomes, ie, chro-
mosomes 1, 2, 6,10,13,17, and 21, were specifically
involved in copy number changes. The loss of all the
seven chromosomes occurred in 10 of 17 cases,
monosomy of six specific chromosomes in 4 cases,
monosomy of five chromosomes in 2 cases, and four
chromosomes in 1 case.
Because CGH provides only data for relative gains
and losses of chromosomes but not for the actual
ploidy, interphase cytogenetics was performed on
single cell suspensions from several tumors (Table 2).
Cytogenetics of Chromophobe RCC 359
AJP August 1994, Vol. 145, No. 2
d
t
Figure 1. a-d: CCD images ofa male metaphase spread hybridized with tumor DNA 315 detected with FITC(a) and (46,XY) control DNA detected
with TRITC(b). The autosomes in a reveal tuo differentfluorescence intensity levels: chromosomes 1, 2, 3, 6, 7, 9, 10, 12, 13, 17, 18, and 21 yield
lower initenisity values that are equal to the fluorescence intensity values of the X chromosome (male patient). A lookup table visualizes the pixel-
by-pixel FITCITR1TC ratios in c. Yellout suggests a balanced state between tumor DNA and the male control DNA, whereas red indicates an under-
represetationlof tlunmor DNA. For chromosome identitication DAPI batnditng uas applied d. Th7e karyotvpe of this tumor was published previously in
(5).
pUC1.77 and pa3.5, which recognize the highly re-
petitive sequences in the centromeric regions of chro-
mosomes 1 and 3, respectively, were chosen be-
cause chromosome 1 yielded a decreased FITC/
TRITC ratio, indicating an underrepresentation of
chromosome 1, whereas chromosome 3 showed a
balanced FITC/TRITC ratio. The hybridization effi-
ciency of the probes was tested on kidney cells from
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Figure 2. a-b: CCD images of a male metaphase spread hybridized
with tumor DNA 277 detected witb FITC b. The hybridization pattern
of the (46,XY) control DNA is not shown. b demonstrates again the
two different fluorescence intensity levels observed in chromophobe
RCC autosomes 1, 2, 6, 10, 13, 17, and 21 are less intensively
painited and display the same fluorescence intensities as the X chro-
mosome ( male patient). Note that the Y chromosome is notpainted at
all, indicatitng a loss of this chromosome in the tumor. a DAPI image
for identification of the chromosomes. The karyotype of this tumor
was puiblished in (6). c-d: CCD images ofafemale metaphase spread.
d displays the FITC image of the hybridization pattern with the tumor
DNA 691; the TRITC image of the control DNA is not shown. Again
the typical two level fluorescence intensity pattern for chromophobe
RCC is visible, indicating loss of autosomes 1, 2, 6, 10, 13, and 21
with fluorescence intensities equal to the X chromosomes (male pa-
tietnt). c DAPI image.
normal kidney tissue (Table 2, 9759/93). Two signals
were counted for both probes in more than 90% of the
nuclei. In contrast, in all tumor samples the chromo-
some 1-specific probe pUC1.77 revealed only one
signal in the majority of cells (78 to 89%), whereas the
chromosome 3-specific probe pa3.5 yielded two sig-
nals in 89% to 91% of cells. Taking into account the
average ratio profiles that showed unequivocally that
only two different FITC/TRITC ratio levels existed (Fig-
ure 3), we concluded that chromosomes with a de-
creased FITC/TRITC ratio corresponded to mono-
somies and the other chromosomes to disomies.
Discussion
In this study we used the recently introduced CGH
technique'011 to analyze 19 chromophobe RCCs.
Our data confirm previous cytogenetic data that these
Figure 3. Average fluorescence ratio profile for tumor 277. The cen-
tral vertical line represents the ratio value typicalfor a balanced state
of chromosome material, wbereas the right and left lines represent
thresbolds for chromosomal gains (right line) and losses (left line).
Gray-shaded regions indicate heterochromatic pericentromeric and
paracentromeric chromosome regions and the short armis of the acro-
centric chromosomes that yield due to the suppression with Cot-1
DNA very low FITC and TRITCfluorescence intensities and are there-
fore excludedfrom evaluation.
tumors are characterized by a combination of multiple
losses of the entire chromosomes 1, 2, 6, 10, 13, 17,
and 21.56
The recurrent loss of a set of 6 or 7 entire chromo-
somes in the vast majority of chromophobe RCCs is
a unique genetic pattern. In contrast, the vast majority
of solid tumors are characterized by complex karyo-
type changes such as monosomies, trisomies, inter-
stitial deletions, and translocations leading to loss,
gains, and rearrangements of different chromosomal
segments. For example, nonpapillary RCC, the most
common type of kidney cancer, has either one, two,
three, or more specific karyotype changes including
deletions, monosomies, trisomies, and balanced or
unbalanced translocations.2
It is likely that multiple hits represent sequential mu-
tations of growth regulatory genes in a single clone.
The loss of chromosome 1 occurred in all chro-
mophobe RCCs where numerical chromosomal
changes were detected, whereas other chromo-
somes were lost only in a fraction of the tumors stud-
ied so far. This finding suggests that chromosome 1
harbors one or several genes whose loss is a nec-
essary condition for the development of chromo-
A
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Table 1. Whole Chromosome Losses Revealed with Comparative Genomic Hybridization
Size of
File Tumor
No. Sex Age (cm) 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 X Y
224 F NK 1.0 ** * * * * * *
229tt F 24 3.5 ** * * * * * * *
277t M 58 4.5 ** * * * * * *
315t§ M 63 6.0 *** ** ** * * * * *
417 M NK 1.0 *** * * * * * *
680 M 61 5.5 * ** * * * * * * * * *
685 M 51 7.5 ** * * * * *
686 M 69 10.0 ** * * * * * *
687 M 60 8.0 ** * * * * *
689 M 43 8.0 ** * * * * *
690 F 81 8.5 ** * * * * *
691 M 42 5.0 ** * * *
692 M 63 4.7 ** * * *
693t M 49 8.6 * * * * * *
694 F 57 4.3 * * * * * * *
695 M 69 7.0 * * * *
696 M 60 4.3 * * * * *
F, female; M, male; NK, not known.
* Loss of one of the homologous autosomes or one of the sex chromosomes.
Previously published in: t6; t7; §5.
phobe RCCs. However, loss of tumor-relevant genes
on chromosome 1 does not seem to be a sufficient
condition because in all tumors studied thus far a se-
ries of specific chromosomes was lost. We expect
that chromosomes 2, 6, 10, 13, 17, and 21 should
harbor additional tumor-relevant genes that also con-
tribute to the formation of this tumor entity when
present in diminished copy number. It seems possible
that mutations of these genes occurred in the cases
in which we observed a balanced state of the respec-
tive chromosomes by CGH. Alternatively, this finding
could suggest that the loss of the entire set of tumor-
relevant genes located on other chromosomes than
chromosome 1 is not absolutely essential for chro-
mophobe RCCs. Whether a specific order of chro-
mosome losses is required or whether the order that
leads to the loss of a specific set of chromosomes
may be random cannot be deduced from these data.
A strong increase of chromosome segregation er-
rors may be the primary event in the development of
chromophobe RCCs.3 Gains or losses may affect all
chromosomes similarly. Selection due to growth ad-
vantages of progenitor cells with specific chromo-
some losses could then explain why a specific pattern
of chromosome losses is found in fully developed
chromophobe RCCs. Currently, we can only specu-
late about the possible genetic events that lead to the
unique pattern of chromosomal losses in this tumor
type.
Errors in the interaction between mitochondrial and
nuclear genes could also be instrumental in the de-
velopment of chromophobe RCCs because gross re-
arrangement of the mitochondrial DNA in chromo-
phobe RCCs was previously described.7
Chromophobe RCC may pose a differential diag-
nostic problem by routine histological examination.
Thoenes et al3 have recognized tumors with a high
number of vesicles (typical variant) and those with a
high number of mitochondria (eosinophilic variant). A
transition between the two types is a common finding
within chromophobe RCCs. The transparent cyto-
plasm of normal variant may resemble "clear" cells
and may be misdiagnosed as a clear cell RCC. The
mitochondria-rich variant of chromophobe RCC,
which is characterized by dense eosinophilic granu-
lar cytoplasm, may resemble a benign oncocytoma
or malignant granular cell RCC. Recent working clas-
sifications are based on cytological and histological
pattern of renal cell tumors. In regard to certain cy-
toplasmic components, the World Health Organiza-
tion describes clear, granular, oncocytic, and spin-
del-shaped cell tumors.24,25 Thoenes et a126
distinguishes clear (typical and eosinophilic variant),
chromophilic (eosinophilic and basophilic variant),
chromophobe (typical and eosinophilic variant),
pleomorphic, and oncocytic cells. Such stratifica-
tions based solely on variable cellular phenotypes
may not be sufficient to discriminate between geneti-
cally distinct entities.
Recent molecular cytogenetic evaluation of renal
cell tumors has recognized genetically and biologi-
cally well-defined entities referred to as papillary renal
cell adenoma and carcinoma, nonpapillary RCC, and
renal oncocytoma.2227 We have now established the
genetic hallmarks for chromophobe RCCs as well.
Each type of kidney cancer is characterized by spe-
cific combinations of genetic changes and some of
them occur exclusively in one of the tumor types.22
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Table 2. Results ofInterphase Cytogenetics
DNA No. of Signals/Cell No.
File No. Probe 0 1 2 3 4 Nuclei
9759/93 pUC1.77 5 92 3 100
pa3.5 5 93 2 100
686 pUC1.77 1 89 12 102
pa3.5 1 2 89 7 3 102
687 pUC1.77 1 87 12 100
pa3.5 2 91 2 5 100
689 pUC1.77 3 78 19 100
pa3.5 2 89 9 100
691 pUC1.77 3 87 13 103
pa3.5 1 91 2 9 103
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